Coronavirus disease 2019 and cardiovascular system: A narrative review

Coronavirus disease 2019 and cardiovascular system: A narrative review

At the end of 2019, a viral pneumonia disease called coronavirus disease 2019 (COVID-19), which is caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV2), emerged in Wuhan, China. This novel disease rapidly spread at an alarming rate that as a result, it has now been declared pandemic...

Full description

Bibliographic Details
Main Authors:	Felix Kwenandar, Karunia Valeriani Japar, Vika Damay, Timotius Ivan Hariyanto, Michael Tanaka, Nata Pratama Hardjo Lugito, Andree Kurniawan
Format:	Article
Language:	English
Published:	Elsevier 2020-08-01
Series:	International Journal of Cardiology: Heart & Vasculature
Subjects:	COVID-19 SARS-CoV-2 Coronavirus Cardiovascular ACE2
Online Access:	http://www.sciencedirect.com/science/article/pii/S2352906720301949

Similar Items

The Use of ACE inhibitor/ARB in SARS-CoV-2 Patients: A Comprehensive Narrative Review
by: Timotius Ivan Hariyanto, et al.
Published: (2020-11-01)

Human immunodeficiency virus and mortality from coronavirus disease 2019: A systematic review and meta-analysis
by: Timotius I. Hariyanto, et al.
Published: (2021-04-01)

Pathogenesis of Acute Kidney Injury in Coronavirus Disease 2019
by: Jing-Yi Qian, et al.
Published: (2021-02-01)

The Ocular Surface and the Coronavirus Disease 2019: Does a Dual ‘Ocular Route’ Exist?
by: Pietro Emanuele Napoli, et al.
Published: (2020-04-01)

CORONAVIRUSES – HOW PROTEIN INTERACTIONS CHANGED OUR PERCEPTION OF THE WORLD
by: Jolanta Bratosiewicz-Wąsik, et al.
Published: (2021-06-01)

Renal Carcinoma Is Associated With Increased Risk of Coronavirus Infections
by: Satyendra C. Tripathi, et al.
Published: (2020-11-01)

Continue ACE inhibitors / ARB’S till further evidence in coronavirus disease 2019 (COVID-19)
by: Sandeep Bansal, et al.
Published: (2020-05-01)

A review on Coronavirus Disease and potentially active drugs targeting Coronavirus
by: Tarawanti Verma, et al.
Published: (2021-01-01)

Eyes on coronavirus
by: Yan-Ping Li, et al.
Published: (2021-03-01)

The ACE2 Receptor for Coronavirus Entry Is Localized at Apical Cell—Cell Junctions of Epithelial Cells
by: Florian Rouaud, et al.
Published: (2022-02-01)

Global Spread of Coronavirus Disease 2019 and Malaria: An Epidemiological Paradox in the Early Stage of A Pandemic
by: Pietro Emanuele Napoli, et al.
Published: (2020-04-01)

From Alpha to Omicron: How Different Variants of Concern of the SARS-Coronavirus-2 Impacted the World
by: Mickensone Andre, et al.
Published: (2023-09-01)

An update on angiotensin-converting enzyme 2 structure/functions, polymorphism, and duplicitous nature in the pathophysiology of coronavirus disease 2019: Implications for vascular and coagulation disease associated with severe acute respiratory syndrome coronavirus infection
by: Christian A. Devaux, et al.
Published: (2022-11-01)

Insights of Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV-2) pandemic: a current review
by: Jyoti Choudhary, et al.
Published: (2021-02-01)

Association of Comorbidities with Coronavirus Disease 2019: A Review
by: Prasenjit Mitra, et al.
Published: (2020-04-01)

A novel coronavirus (SARS-CoV-2): current status and challenges
by: Nilay Vishal Singh, et al.
Published: (2022-05-01)

Editorial: Dyslipidemia, obesity and coronavirus disease 2019 (COVID-19)
by: Timotius Ivan Hariyanto, et al.
Published: (2022-11-01)

Distribution of Coronavirus Receptors in the Swine Respiratory and Intestinal Tract
by: Rahul Kumar Nelli, et al.
Published: (2022-09-01)

Lock, Stock and Barrel: Role of Renin-Angiotensin-Aldosterone System in Coronavirus Disease 2019
by: Christian Zanza, et al.
Published: (2021-07-01)

Severe Acute Respiratory Syndrome Coronavirus 2-Induced Neurological Complications
by: Shijia Yu, et al.
Published: (2020-12-01)

The clinical features of COVID-19 patients with positive viral RNA stool test results and possibility of fecal-oral transmission : A Systematic Review
by: Selina Natalia, et al.
Published: (2021-05-01)

Are new genome variants detected in SARS-CoV-2 expected considering population dynamics in viruses?
by: Ergoren Mahmut Cerkez, et al.
Published: (2021-01-01)

Editorial: Coronavirus Evolution, Cross-Species Transmission and Recombination
by: Sunil K. Lal
Published: (2022-01-01)

Binding affinity between coronavirus spike protein and human ACE2 receptor
by: Marcus Ho-Hin Shum, et al.
Published: (2024-12-01)

Natural Flavonoids as Potential Angiotensin-Converting Enzyme 2 Inhibitors for Anti-SARS-CoV-2
by: Muchtaridi Muchtaridi, et al.
Published: (2020-09-01)

The Potential Role of Osteopontin and Furin in Worsening Disease Outcomes in COVID-19 Patients with Pre-Existing Diabetes
by: Yvonne Adu-Agyeiwaah, et al.
Published: (2020-11-01)

Identification of a novel lineage bat SARS-related coronaviruses that use bat ACE2 receptor
by: Hua Guo, et al.
Published: (2021-01-01)

Genetic alteration, RNA expression, and DNA methylation profiling of coronavirus disease 2019 (COVID-19) receptor ACE2 in malignancies: a pan-cancer analysis
by: Peiwei Chai, et al.
Published: (2020-05-01)

Essential thrombocythemia, hemolytic anemia and hepatic cirrhosis: Could there be an association?
by: Nata Pratama Hardjo Lugito, et al.
Published: (2018-09-01)

Comparison of renin–angiotensin–aldosterone system inhibitors with other antihypertensives in association with coronavirus disease-19 clinical outcomes
by: Yihienew M. Bezabih, et al.
Published: (2021-06-01)

Coronavirus disease 2019 and its potential animal reservoirs: A review
by: Md. Sirazul Islam, et al.
Published: (2021-08-01)

Mass Spectrometry and Structural Biology Techniques in the Studies on the Coronavirus-Receptor Interaction
by: Danuta Witkowska
Published: (2020-09-01)

Coronavirus Disease-2019 Conundrum: RAS Blockade and Geriatric-Associated Neuropsychiatric Disorders
by: Aline Silva de Miranda, et al.
Published: (2020-08-01)

Target-Centered Drug Repurposing Predictions of Human Angiotensin-Converting Enzyme 2 (ACE2) and Transmembrane Protease Serine Subtype 2 (TMPRSS2) Interacting Approved Drugs for Coronavirus Disease 2019 (COVID-19) Treatment through a Drug-Target Interaction Deep Learning Model
by: Yoonjung Choi, et al.
Published: (2020-11-01)

Natural and Nature-Derived Products Targeting Human Coronaviruses
by: Konstantina Vougogiannopoulou, et al.
Published: (2021-01-01)

Unravelling Antigenic Cross-Reactions toward the World of Coronaviruses: Extent of the Stability of Shared Epitopes and SARS-CoV-2 Anti-Spike Cross-Neutralizing Antibodies
by: Christian A. Devaux, et al.
Published: (2023-05-01)

Safety and Immunogenicity of a Single Dose of BNT162b2 COVID-19 mRNA Vaccine in a Warfarin-Treated Protein S Deficient Patient: A Case Report and Literature Review
by: Cucunawangsih Cucunawangsih, et al.
Published: (2022-12-01)

Coronavirus disease 2019; epidemiology and recommendations
by: Mousa Ghelichi-Ghojogh, et al.
Published: (2020-01-01)

Smoking Is Correlated With the Prognosis of Coronavirus Disease 2019 (COVID-19) Patients: An Observational Study
by: Fei Peng, et al.
Published: (2021-03-01)

Covid 19-the 21st Century Pandemic: The Novel Coronavirus Outbreak and the Treatment Strategies
by: Sherin Joseph, et al.
Published: (2022-01-01)